Linden Capital Partners Acquires Majority Stake in RQM+
August 16, 2021
Chicago-based Linden Capital Partners completed a majority investment in RQM+ (headquartered in Monroeville, Pennsylvania), partnering with the company’s founders and management to accelerate growth and expand regulatory, quality, and compliance services for medical device and IVD manufacturers. The transaction represents a sale by prior investors DFW Capital Partners and Chartwell/Chief Capital and will support organic growth and acquisitions to broaden RQM+’s service offerings.
- Buyers
- Linden Capital Partners
- Targets
- RQM+ Corp.
- Sellers
- DFW Capital Partners, Chartwell Investments Entrepreneur & Founder Capital (Chief Capital)
- Industry
- Medical Devices
- Location
- Pennsylvania, United States
- Transaction Type
- Buyout
Explore More
Related Acquisitions
-
RQM+ (Linden Capital) Acquires Jordi Labs
September 7, 2022
Healthcare Services
RQM+, a MedTech CRO and portfolio company of Linden Capital Partners, has acquired Jordi Labs, a specialist analytical chemistry and laboratory testing provider serving medical device and pharmaceutical customers. The deal strengthens RQM+'s lab services and extractables & leachables capabilities to support regulatory submissions and product development; Harris Williams advised Jordi Labs on the transaction.
-
DFW Capital Partners and Chief Capital Make Growth Investment in Regulatory and Quality Solutions (R&Q)
October 10, 2019
Healthcare Services
DFW Capital Partners, in partnership with Chief Capital (Chartwell Investments Entrepreneur & Founder Capital), completed a growth investment in Regulatory and Quality Solutions (R&Q), a regulatory and product quality consulting firm serving medical device, IVD and combination product manufacturers. The investment will support R&Q's continued expansion and the firms have added DFW operating partner Kurt Brykman to R&Q's board to help accelerate growth and capability development.
-
RQM+ Acquires Libra Medical
May 10, 2023
Healthcare Services
RQM+, a global MedTech regulatory and clinical services provider, has acquired Libra Medical, a contract research organization (CRO) specializing in early-stage clinical trials for complex medical devices and diagnostics. The acquisition expands RQM+'s clinical trial capabilities—particularly first-in-human (FIH) studies, regulatory affairs and quality assurance—and brings Libra's founder, Dr. Sew-Wah Tay, into RQM+ to continue client relationships.
-
RQM+ Acquires AcKnowledge Regulatory Strategies
January 4, 2022
Healthcare Services
RQM+ Corp. acquired AcKnowledge Regulatory Strategies, a San Diego-based regulatory affairs consultancy specializing in medical device and IVD submissions. The add-on expands RQM+’s FDA submission expertise and regulatory capabilities, bringing the AcKnowledge team and founder Allison Komiyama into RQM+’s network; RQM+ is backed by Linden Capital Partners.
-
RQM+ Acquires Germany-Based CRO Kottmann
August 28, 2023
Healthcare Services
RQM+, a global MedTech services and CRO provider, has acquired CRO Dr. med. Kottmann, a Germany-based contract research organization specializing in clinical studies for medical devices, IVDs and pharmaceuticals. The acquisition expands RQM+'s presence and capabilities in Germany and across Europe, strengthening end-to-end clinical support for its clients.
-
Regulatory and Quality Solutions (R&Q) Acquires Maetrics
September 10, 2020
Medical Devices
Regulatory and Quality Solutions LLC (R&Q) acquired Maetrics LLC on September 10, 2020 to create an enlarged global regulatory and quality consultancy focused on medical devices, diagnostics, and pharmaceuticals. The combination brings together R&Q's regulatory services with Maetrics' international footprint and expertise to form the largest medical device–focused regulatory and quality consultancy.
Track M&A activity that matters to you
Get real-time deal alerts, build buyer lists with AI, and access our full acquisition database. Start your free trial today.